"Increasingly, urologists are faced with patients who cannot safely discontinue anticoagulation or antiplatelet medications, even in the face of an impending surgical procedure. This is a trend that is likely to continue into the foreseeable future," writes Brian R. Matlaga, MD, MPH.
A study evaluating the oxalate content of foods as reported by two reputable sources shows discordance.
A large new study provides more evidence that cholesterol drugs may lower kidney stone formation.
A recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.
Other products discussed include a stent system for treating ureteral obstructions, a male infertility test, and more.
Henry Rosevear, MD, discusses the ten things he’d like to see happen in 2017 for the field of urology.
Other pipeline developments discussed include a bladder cancer test, a male infertility assay, and the first oral dosage treatment for hypogonadism.
Percutaneous nephrolithotomy in the presence of aspirin appears both effective and safe. In a retrospective review of almost 300 PCNL cases, postoperative hemorrhage was uncommon in patients who continued aspirin preoperatively, said Brandon Otto, MD, at the AUA annual meeting in San Diego.
“Our research shows that the implications of kidney stones may go beyond the discomfort they are so often associated with,” says co-lead author Andrew Rule, MD.
Other new products discussed in this article include a surgical training model, devices designed to improve prostate biopsy accuracy, an updated label and more.